~~<i id='80CB1023EB'><strike id='80CB1023EB'><tt id='80CB1023EB'><pre id='80CB1023EB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：knowledge 2025-09-29 12:05:39 - browse：4231

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： American woman, child freed after being kidnapped in Haiti last month

hotspot

entertainment

Wikipedia

focus

hotspot

TheWhiteHouseoutlineditseffortstoendshortagesofthreekeygenericchemotherapies.Butexpertswantmoremored

WSS

Will the IRA bring competition to the biologics market?

FDA approves updated Covid vaccines

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

WATCH: Why do bright lights make us see spots?

The best solution to the drug shortages problem

The best solution to the drug shortages problem

hotspot

leisure time

hotspot

Sports medicine is finally prioritizing gender equality

Diverse clinical trials: Why aren’t we there yet?

Peter Hotez and the public health issue of online harassment

The best solution to the drug shortages problem

New air purifier tech could be key to improving indoor air quality

Anavex keeps shifting the goalposts in its clinical trials

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Police still searching for prisoner who escaped from NYC hospital

In age of alternative facts, a scholarly course on calling out crap

White House touts steps to stem shortages of cancer treatments

entertainment

Food makers tried to stack nutrition panel with preferred experts

Will the IRA bring competition to the biologics market?

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

American woman, child freed after being kidnapped in Haiti last month

Generate Biomedicines machine learning biotech raises $273M

How to make the FDA’s new prescription one

Wikipedia

focus

hotspot

hotspot